Translating Cancer Prevention Research in the Developing World

将癌症预防研究转化为发展中国家

基本信息

  • 批准号:
    8130350
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-02-01 至 2012-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Meeting grant support is requested for a scientific workshop entitled, "Translating Cancer Prevention Research in Developing Countries". This workshop will be held at the Crowne Plaza Hotel and Mazumdar Shaw Cancer Center in Bangalore, India, on February 13-17, 2011. The organizing committee for this workshop consists of Drs. Dean Brenner (USA), Madhuri Kakarala (USA), Kishore Chaudhry (India) and M. Abraham Kuriakose (India). The objectives of this conference are: 1: To identify overlapping mutually beneficial translational cancer prevention research questions that address cancer prevention and control priorities in India and the United States through: a. Comparing and contrasting cancer prevention research scientific strategies in various countries. b. Identifying the resources available and necessary infrastructure to support collaborative translational cancer prevention research among developing countries using India as an example and developed countries using the United States as an example. 2: To review and compare population based gene-environment interactions in Indian populations with those of other countries. 3: To review preventive strategies in organ site specific high incidence and mortality cancers common to India, Europe and the United States (airway, breast, cervix) that: a. Embrace and respect local culture and traditions and provide leads for cancer risk reduction strategies. b. Have potential to deploy to impoverished rural populations at low cost with minimal technological complexity. c. Will lead to cancer incidence and mortality reductions in developing and developed countries. Conferees are invited based upon their diversity in scientific discipline, interactive and collaborative experience and track-record, and perceived willingness to alter preconceptions in order to accommodate new information and reformulate future research plans. The Conference is intense and modeled after the Gordon Conferences. It requires conferees to remain segregated as a group for four days, working closely together. Meals and free time are structured to enhance the opportunities of conferees to interact informally. The Conference features panels consisting of 10 minute lectures, frequent discussion periods, multiple 60 minute panel discussions, lunch and dinner periods with focused group meetings, and an end of conference summary document from each of 7 panel discussions to create the need for closure and focus. The summary documents and speaker papers will be submitted for publication in Cancer Prevention and Cancer Biomarkers after appropriate peer review. By intensively interacting, conferees will become familiar with each other, will understand the strengths and weaknesses of the diverse disciplines represented at the meeting, and will recognize and establish cross disciplinary interactions to create necessary scientific critical masses to advance the field. PUBLIC HEALTH RELEVANCE: This workshop addresses cancer prevention on a global health scale. It addresses the key issues of translation of cancer prevention research to population and clinical application in a large, diverse developing country and its potential benefit world-wide. The workshop is designed to maximize the opportunities for collaboration, creating an environment in which scientists may exchange concepts and samples, thus permitting comparison of data from diverse genetic pools. Such infrastructure is crucial to the future development and deployment of cost effective, cancer early detection and screening technologies aimed at reducing mortality on a global scale, particularly in large population, cost constrained environments.
描述(由申请人提供):会议补助金支持要求为一个科学研讨会,题为“翻译发展中国家的癌症预防研究”。该研讨会将于2011年2月13日至17日在印度班加罗尔的皇冠假日酒店和Mazumdar Shaw癌症中心举行。这次研讨会的组织委员会由Dean Brenner博士(美国)、Madhuri Kakarala(美国)、Kishore Chaudhry(印度)和M. Abraham Kuriakose(印度)。这次会议的目标是: 一曰:确定重叠的互惠转化癌症预防研究问题,通过以下方式解决印度和美国的癌症预防和控制优先事项: a.比较和对比不同国家的癌症预防研究科学策略。 B.确定可用的资源和必要的基础设施,以支持以印度为例的发展中国家和以美国为例的发达国家之间的合作转化癌症预防研究。 2:审查和比较印度人口与其他国家人口的基因-环境相互作用。 第三章:审查印度、欧洲和美国常见的器官部位特异性高发病率和死亡率癌症(气道、乳腺、宫颈)的预防策略: a.拥抱和尊重当地文化和传统,为降低癌症风险战略提供指导。 B.有可能以低成本和最低的技术复杂性部署到贫困的农村人口。 C.将导致发展中国家和发达国家的癌症发病率和死亡率下降。 邀请与会者的依据是他们在科学学科、互动和协作经验和跟踪记录方面的多样性,以及改变先入为主的观念以适应新信息和重新制定未来研究计划的意愿。会议是紧张的,仿照戈登会议。它要求与会者作为一个小组保持隔离四天,密切合作。安排膳食和空闲时间是为了增加与会者进行非正式互动的机会。会议的特点包括10分钟的讲座,频繁的讨论时间,多个60分钟的小组讨论,午餐和晚餐时间与重点小组会议,并从7个小组讨论的每一个会议总结文件结束,以创建关闭和重点的需要。摘要文件和演讲者论文将在适当的同行评审后提交发表在《癌症预防和癌症生物标志物》上。通过深入的互动,与会者将相互熟悉,了解会议上所代表的不同学科的优势和劣势,并将认识和建立跨学科的互动,以创造必要的科学临界群众来推进该领域。 公共卫生相关性:本研讨会讨论全球健康范围内的癌症预防。它解决了癌症预防研究转化为人口和临床应用在一个大的,多样化的发展中国家及其潜在的利益全世界的关键问题。讲习班旨在最大限度地扩大合作机会,创造一个科学家可以交流概念和样本的环境,从而能够比较来自不同基因库的数据。这种基础设施对于未来开发和部署具有成本效益的癌症早期检测和筛查技术至关重要,这些技术旨在降低全球范围内的死亡率,特别是在人口众多、成本有限的环境中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dean E. Brenner其他文献

Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbit.
烯丙醇诱导的亚致死肝损伤对阿霉素代谢和毒性的影响。
  • DOI:
  • 发表时间:
    1987
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Dean E. Brenner;Anthony Lb;Susan A. Halter;Nancy Lee Harris;Jerry C. Collins;Kenneth R. Hande
  • 通讯作者:
    Kenneth R. Hande
Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?
  • DOI:
    10.1007/s10620-015-3575-2
  • 发表时间:
    2015-02-14
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Robert S. Bresalier;Scott Kopetz;Dean E. Brenner
  • 通讯作者:
    Dean E. Brenner
Su562 DOES MUCOSAL <em>AKKERMANSIA</em> ABUNDANCE PREDICT OMEGA FATTY ACIDS AND PGE2 PRODUCTION AFTER DIETARY INTERVENTION?
  • DOI:
    10.1016/s0016-5085(21)02479-3
  • 发表时间:
    2021-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Samara Rifkin;Ananda Sen;D.K. Turgeon;Mack T. Ruffin;Dean E. Brenner;Patrick D. Schloss;Zora Djuric
  • 通讯作者:
    Zora Djuric
Serum and Plasma Collection
血清和血浆采集
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Tuck;D. Kim Turgeon;Dean E. Brenner
  • 通讯作者:
    Dean E. Brenner
Multiplex characterization of circulating tumor cells from ductal carcinoma in situ patients suggests early tumor dissemination
对导管原位癌患者循环肿瘤细胞的多重特征分析表明肿瘤早期扩散
  • DOI:
    10.1016/j.canlet.2025.217703
  • 发表时间:
    2025-07-28
  • 期刊:
  • 影响因子:
    10.100
  • 作者:
    Brittany Rupp;Neha Nagpal;Brooke Thanasiu;Kristen Tuck;Kirk Herman;Dean E. Brenner;Justin Colacino;Max Wicha;Sunitha Nagrath
  • 通讯作者:
    Sunitha Nagrath

Dean E. Brenner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dean E. Brenner', 18)}}的其他基金

Early Phase Clinical Cancer Prevention Consortium
早期临床癌症预防联盟
  • 批准号:
    10212345
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
Early Phase Clinical Cancer Prevention Consortium
早期临床癌症预防联盟
  • 批准号:
    10459458
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
Early Phase Clinical Cancer Prevention Consortium
早期临床癌症预防联盟
  • 批准号:
    10002730
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
Early Phase Clinical Cancer Prevention Consortium
早期临床癌症预防联盟
  • 批准号:
    10683160
  • 财政年份:
    2020
  • 资助金额:
    $ 2.5万
  • 项目类别:
P1 - Omega-3 fatty acids and Colorectal Cancer Prevention
P1 - Omega-3 脂肪酸和结直肠癌预防
  • 批准号:
    8729837
  • 财政年份:
    2013
  • 资助金额:
    $ 2.5万
  • 项目类别:
P1 - Omega-3 fatty acids and Colorectal Cancer Prevention
P1 - Omega-3 脂肪酸和结直肠癌预防
  • 批准号:
    7893330
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:
Translational Research in GI Cancer
胃肠道癌症的转化研究
  • 批准号:
    8540123
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:
Translational Research in GI Cancer
胃肠道癌症的转化研究
  • 批准号:
    8396640
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:
Translational Research in GI Cancer
胃肠道癌症的转化研究
  • 批准号:
    7866992
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:
Translational Research in GI Cancer
胃肠道癌症的转化研究
  • 批准号:
    8868250
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了